Home > Products and Services > Genetic Screening Services

Genetic Screening Services

MGRC's services for point-of-care facilities aim to improve outcomes and the quality of interaction between healthcare professionals and patients. We offer a comprehensive range of genetic screening tests, which are designed to provide genetic information which can help physicians and doctors identify predispositions towards genetic diseases and possible adverse drug reactions in individuals. The choice of these tests depends on the level of detail being sought.

We offer arrays that cater to applications for:

  • Single Nucleotide Polymorphism (SNP) Genotyping and CNV Analysis
  • Custom Genotyping
  • Cytogenetic Analysis
  • Focused Genotyping
  • Linkage Analysis
  • Whole-Genome Genotyping and Copy Number Analysis
  • Gene Regulation and Epigenetic Analysis
  • Array-Based Methylation Analysis
  • Gene Expression Analysis
  • Array-Based Transcriptome Analysis
  • FFPE Sample Analysis
  • Whole-Genome Gene Expression Analysis
  • Comparative Genomic Hybridisation (CGH)


Genetic Screening Analysis

As medical professionals, you will have access to all the data generated by any test. The downstream analysis offered by MGRC as part of this service will generate a comprehensive report, which is structured to provide you and your patients with relevant information on each trait identified. Reports are reviewed by geneticists to highlight anything in the data that may be relevant to the well-being of your patients.

Each analysis report will contain:

Genotyping results need to be interpreted in the context of both current medical best practices and ongoing advances specific to a trait.
A description as to whether the trait is an inherited disease, a genetic disorder, or whether it presents a known pharmacological response. Also included are the characteristics of the trait, symptoms that may develop as a condition manifests, and an identification of early warning signs that could possibly indicate its onset. The information will also explain how the risk probability or risk ratio has been derived.
Information on the prevalence of this trait amongst the different ethnic groups and/or geographic patterns, revealing areas where carriers may or may not become affected. This will deepen the understanding of the origins and environmental factors that influence the chances of a carrier becoming affected.
Information on possible inherent risks, based on the current state of healthcare, and the scientific and technological developments of the respective traits.
Access to links and other sources of information for each identified trait available within the directory.


Click here to view Info Sheet.